Introgen Obtains Exclusive US Patent for Development of Adenoviral Vector Based Gene Therapies

23.07.2007

Introgen Therapeutics Inc. announced in a Wednesday press release that a patent has been awarded titled "Diminishing Viral Gene Expression by Promoter Replacement" by the US Patent and Trademark Office focusing on adenoviral vector development, which is the most commercially important type of viral vector used in the field of gene therapy.

Syria to Introduce Patents and Utility Models Law

16.07.2007

The advisory committee, formed by the Syrian Minister of Economy and Trade Amir Husni Lutfi, has completed and handed over the Patents and Utility Models draft Law to the Ministers' Council, well-informed sources told ag-IP-news Agency.

IBM Pledges Free Access to Patents Involved in Implementing 150+ Software Standards

16.07.2007

IBM announced in a Thursday press release that it is granted universal and perpetual access to certain intellectual property that might be necessary to implement more than 150 standards designed to make software interoperable.

Ciphergen Biosystems Receives Notice of Intent from USPTO

16.07.2007

Ciphergen Biosystems Inc. announced in a Thursday press release that the company received from the United States Patent and Trademark Office (USPTO) a notice of intent to issue a Reexamination Certificate of US Patent No. 6,734,022, which is directed to a fundamental process of SELDI mass spectrometry.

CAMBIA Pools in Australian Patents

16.07.2007

CAMBIA announced in a Thursday press release that for the first time, the full text of Australian patents can be searched, viewed and printed at no cost, by anyone, thanks to a non-profit international organization based in Canberra.

Visto and SEVEN Announce Litigation Settlement

16.07.2007

SEVEN Networks and Visto Corporation announced on Wednesday that the two companies have entered into a settlement, which ends a three-year patent dispute between the parties.